This article looks at the possible risks and benefits of ketamine-assisted psychotherapy.
Read moreKetamine for Depression
Here’s a look at the current research on ketamine for depression and mood disorders.
Read moreResearch on 5-MeO-DMT
In addition to reducing symptoms of depression, the psychedelic drug 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) appears to cause changes in inflammatory biomarkers.
Read moreMagic Mushroom Nasal Spray
A ‘magic mushroom’ nasal spray has been designed to make microdosing easier for people trying to treat PTSD or depression. An Oregon company has developed a magic mushroom nasal spray in Jamaica – where psilocybin is legal – for controlled, metered-dosing known as ‘microdosing’.
Read morePsilocybin Therapy for Major Depression
The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).
Read moreA Personal Accountant of Ayahuasca and Depression
Keep reading for an anthropologist’s account of how ayahuasca helped with his depression.
Read moreAyahuasca for Depression
Here’s a look at some recent research looking at whether ayahuasca can help with depression.
Read moreDosed Documentary
Check out the documentary Dosed, from the Melbourne Documentary Film Festival 2019. Winner of Audience Award for Best Documentary.
Read morePsilocybin Being Researched As Aid for Alzheimer's and Depression
The largest psychedelic research center in the world, and the first of its kind in the United States, will open at Johns Hopkins Medicine in Maryland. Funded by $17 million from private donors, the Center for Psychedelic and Consciousness Research will conduct research into the use of psychedelic drugs in the treatment of addiction, PTSD, depression, Alzheimer's disease and more.
Read moreAyahuasca and Depression
This study from Brazil shows that ayahuasca may ease severe depression.
Read moreAre Magic Mushrooms the Next Antidepressants?
“Hallucination-inducing drugs like magic mushrooms could be about to break big pharma’s stranglehold on the hugely lucrative market for antidepressants, according to the head of the world’s first centre for psychedelic research.”
Read more